NSD1 and breast carcinoma: Chen et al. (2022) showed that high expression of the histone lysine methyltransferase NSD1 (nuclear receptor binding SET domain-containing protein 1) could predict the overall survival of breast cancer patients, although the subtype of breast cancer that was analyzed was not discussed.